ATE83931T1 - Methode fuer die behandlung von viraler gehirnentzuendung. - Google Patents

Methode fuer die behandlung von viraler gehirnentzuendung.

Info

Publication number
ATE83931T1
ATE83931T1 AT88114517T AT88114517T ATE83931T1 AT E83931 T1 ATE83931 T1 AT E83931T1 AT 88114517 T AT88114517 T AT 88114517T AT 88114517 T AT88114517 T AT 88114517T AT E83931 T1 ATE83931 T1 AT E83931T1
Authority
AT
Austria
Prior art keywords
treatment
biologic
viral
cerebral inflammation
vivo subject
Prior art date
Application number
AT88114517T
Other languages
English (en)
Inventor
Robert L Stout
Original Assignee
Clinical Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Biotechnologies Inc filed Critical Clinical Biotechnologies Inc
Application granted granted Critical
Publication of ATE83931T1 publication Critical patent/ATE83931T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT88114517T 1987-09-22 1988-09-06 Methode fuer die behandlung von viraler gehirnentzuendung. ATE83931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9953187A 1987-09-22 1987-09-22
EP88114517A EP0308717B1 (de) 1987-09-22 1988-09-06 Methode für die Behandlung von viraler Gehirnentzündung

Publications (1)

Publication Number Publication Date
ATE83931T1 true ATE83931T1 (de) 1993-01-15

Family

ID=22275455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88114517T ATE83931T1 (de) 1987-09-22 1988-09-06 Methode fuer die behandlung von viraler gehirnentzuendung.

Country Status (3)

Country Link
EP (1) EP0308717B1 (de)
AT (1) ATE83931T1 (de)
DE (1) DE3877102T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572834A (en) * 1984-04-10 1986-02-25 Clinical Reference Laboratory, Inc. Biologic and method of preparing same

Also Published As

Publication number Publication date
EP0308717A3 (en) 1990-02-14
DE3877102D1 (de) 1993-02-11
EP0308717A2 (de) 1989-03-29
EP0308717B1 (de) 1992-12-30
DE3877102T2 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
US4632980B1 (de)
Thier et al. Cystinuria: in vitro demonstration of an intestinal transport defect
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ATE183087T1 (de) Verwendung von beta-hydroxy-beta- methylbutyratsäuere zur förderung der stickstoffzurückhaltung beim menschen
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
SE8703625D0 (sv) New medical use
EP0553291A4 (en) Treatment of autoimmune diseases by oral administration of autoantigens
ZM9387A1 (en) Treatment of diseases caused by viruses
NO934851D0 (no) Fremgangsmaate for stimulering av immunrespons
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
ATE83931T1 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
Bauer et al. Investigations of trace metal content of normal and diseased nails.
RU97115801A (ru) Способ лечения стенозирующих ларинготрахеитов у детей
SU1069818A1 (ru) Способ профилактики гриппа
RU2014020C1 (ru) Способ лечения стилоидита
GR3006147T3 (de)
PT85076A (en) Method for the treatment of infections disease by administration of tumor necrosis factor-alpha
宋宝珠 et al. SHORT-TERM EFFECT IN 135 CASES OF ENURESIS TREATED BY WRIST-ANKLE NEEDLING
Valdimarsdottir The effects of relaxation training and experimental stressors on the immune system.
SU839546A1 (ru) Способ лечени демпинг-синдрома
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
Mutoh Effect of postnatal anoxia on seizure susceptibility in rats: bicuculline-induced seizures and pretreatment with iproniazid

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties